Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Captain Jack who wrote (8324)	1/7/2000 10:33:00 PM
From: Ron Woods	Respond to of 9523

CJ, Loved your profile page. I think PFE is solid with its lipitor deal, and I suspect it will eventually win out with the WLA prospect (just a feeling), so I'm hoping for a good year. But I'm a long term buy and hold type ( hate to pay the Unc), and I'm betting on PFE's good management and pipeline, as well as their R&D, to come through over the next few years. Good Luck. RAW

To: Captain Jack who wrote (8324)	1/11/2000 1:00:00 AM
From: Bong Lewis	Respond to of 9523

smart guy. ditto.

To: Captain Jack who wrote (8324)	1/13/2000 12:34:00 PM
From: Joe S Pack	Read Replies (1) \| Respond to of 9523

CJ, Good timing. PFE and WLA to discuss merger now. dailynews.yahoo.com Warner-Lambert To Hold Pfizer Talks By PHIL GALEWITZ AP Business Writer NEW YORK (AP) - Warner-Lambert (NYSE:WLA - news) Co. today reversed course and said it would hold merger talks with Pfizer Inc (NYSE:PFE - news). The decision came two months after Warner-Lambert agreed to be acquired by American Home Products. Either combination would create the world's largest drugmaker. Investors had pressured Warner-Lambert executives to re-evaluate its decision to unite with American Home Product, especially in light of the rising value of Pfizer's offer. Pfizer's offer is now worth about $75 billion. American Home's bid is valued at less than $51 billion. The difference between the offers has widened in recent weeks due to Pfizer's rising stock price and American Home's falling stock price. Warner-Lambert, the fastest growing major drugmaker, is the world's 15th largest prescription drug company. The Morris Plains N.J.-based company makes the blockbuster cholesterol-lowering drug Lipitor, which it co-markets with Pfizer and which is expected to have $3.3 billion in sales this year and upwards of $6 billion in 2002. In a statement this morning, Warner-Lambert's board said that ``in light of changing circumstances' it had concluded Pfizer's offer ``is better financially for Warner-Lambert shareholders than the proposed merger with American Home Products.' Lodewijk J.R. de Vink, chairman, president and chief executive officer of Warner-Lambert, said talks would be held with Pfizer. Warner-Lambert said it could not guarantee that an agreement could be reached with Pfizer. The battle for Warner-Lambert has escalated into some nasty exchanges between the companies' top officials and several lawsuits have been filed. Warner-Lambert has even sought to terminate Pfizer's rights to co-market and share profits from Lipitor. None of the cases has yet to go to trial. Warner-Lambert has hired Bear Stearns & Co. and Goldman Sachs & Co. to act as its financial advisers in dealing with Pfizer. -Nat